0001213900-20-031426.txt : 20201015
0001213900-20-031426.hdr.sgml : 20201015
20201015133123
ACCESSION NUMBER: 0001213900-20-031426
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201015
FILED AS OF DATE: 20201015
DATE AS OF CHANGE: 20201015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldstein Boris
CENTRAL INDEX KEY: 0001443248
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56216
FILM NUMBER: 201241169
MAIL ADDRESS:
STREET 1: 45 WEST34 ST. 800
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRAIN SCIENTIFIC INC.
CENTRAL INDEX KEY: 0001662382
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 810876714
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 WILBUR PLACE, SUITE 170
CITY: BOHEMIA
STATE: NY
ZIP: 11716
BUSINESS PHONE: (646) 388-3788
MAIL ADDRESS:
STREET 1: 125 WILBUR PLACE, SUITE 170
CITY: BOHEMIA
STATE: NY
ZIP: 11716
FORMER COMPANY:
FORMER CONFORMED NAME: All Soft Gels Inc
DATE OF NAME CHANGE: 20151229
3
1
ownership.xml
X0206
3
2020-10-15
0
0001662382
BRAIN SCIENTIFIC INC.
BRSF
0001443248
Goldstein Boris
C/O BRAIN SCIENTIFIC INC.
125 WILBUR PLACE, SUITE 170
BOHEMIA
NY
11716
1
1
1
0
Chairman of the Board & EVP
Common Stock, par value $0.001 per share
328125
D
Common Stock, par value $0.001 per share
337450
I
By wife
Common Stock, par value $0.001 per share
6749000
I
By High Technology Capital Fund LP
Employee Stock Options (right to buy)
0.75
2029-01-14
Common Stock, par value $0.001 per share
800000
D
Employee Stock Options (right to buy)
0.75
2030-01-30
Common Stock, par value $0.001 per share
800000
D
The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The reporting person is the manager of High Technology Capital Management LLC (the "LLC"), the general partner of High Technology Capital Fund LP (the "LP"). As the manager of the LLC, the reporting person has voting and dispositive control over the shares owned by the LP. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The options vest over a 24-month period as follows: 25% (or 200,000) shall vest six months after the grant date of January 14, 2019, with the remaining options vesting on a monthly basis at a rate of 1/24th per month.
The options vest over a 24-month period after the grant date of January 30, 2020, on a monthly basis at a rate of 1/24th per month.
/s/ Boris Goldstein
2020-10-15